RUBEN W CHIN

Allopathic & Osteopathic Physicians|Internal Medicine ANAHEIM, CA NPI 1902829450

General Payments — all program years on this page

$17,859.85

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 325
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,901.42 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,901.4219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $3,546.3261
2019 $5,081.3292
2020 $1,660.7863
2021 $1,622.9644
2022 $2,112.3326
2023 $1,934.7220
2024 $1,901.4219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096655938 Novo Nordisk Inc $26.80 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103460968 ABBVIE INC. $125.00 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103460970 ABBVIE INC. $8.25 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104202649 AstraZeneca Pharmaceuticals LP $16.69 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104389625 AstraZeneca Pharmaceuticals LP $125.00 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105369140 AstraZeneca Pharmaceuticals LP $125.00 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116150120 GlaxoSmithKline, LLC. $118.80 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117787803 Corcept Therapeutics $115.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117787897 Corcept Therapeutics $114.37 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118228936 Boehringer Ingelheim Pharmaceuticals, Inc. $119.66 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118228938 Boehringer Ingelheim Pharmaceuticals, Inc. $121.58 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135393383 Lilly USA, LLC $120.49 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135393385 Lilly USA, LLC $120.39 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136275041 SCILEX PHARMACEUTICALS INC. $141.13 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141838426 Merck Sharp & Dohme LLC $124.99 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151049470 Phathom Pharmaceuticals, Inc. $113.28 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151049472 Phathom Pharmaceuticals, Inc. $15.45 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151049474 Phathom Pharmaceuticals, Inc. $124.99 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154895516 Kiniksa Pharmaceuticals International, plc $124.55 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.